OncoSec Medical Incorporated (ONCSQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Dec 24, 2024, 4:00 PM EST
OncoSec Medical Cash Flow Statement
Financials in millions USD. Fiscal year is August - July.
Millions USD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
---|---|---|---|---|---|---|---|
Period Ending | Jan '23 Jan 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 | Jul '19 Jul 31, 2019 | Jul '18 Jul 31, 2018 | 2017 - 2013 |
Net Income | -29.39 | -34.18 | -45.17 | -42.25 | -30.28 | -39.14 | Upgrade
|
Depreciation & Amortization | 0.94 | 1.07 | 1.08 | 0.99 | 0.24 | 0.33 | Upgrade
|
Other Amortization | 0.01 | - | - | - | - | - | Upgrade
|
Loss (Gain) From Sale of Assets | -0 | - | - | - | 0 | 0.88 | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | - | - | -0.05 | -0.03 | Upgrade
|
Stock-Based Compensation | 1.28 | 1.69 | 5.6 | 4.45 | 4.35 | 10.1 | Upgrade
|
Other Operating Activities | 0.11 | 0.51 | -0.82 | -0.1 | 0.28 | 2.47 | Upgrade
|
Change in Accounts Payable | 1.13 | -1.38 | -2.56 | 3.62 | -0.74 | 1.43 | Upgrade
|
Change in Other Net Operating Assets | 0.92 | 0.15 | 0.07 | 0.15 | -2.81 | 0.74 | Upgrade
|
Operating Cash Flow | -24.99 | -32.14 | -41.79 | -33.15 | -29 | -23.22 | Upgrade
|
Capital Expenditures | -0.02 | -0.24 | -0.3 | - | -0.01 | -0.07 | Upgrade
|
Sale (Purchase) of Intangibles | - | - | -0.5 | - | - | - | Upgrade
|
Investment in Securities | - | - | - | - | 23.21 | -23.22 | Upgrade
|
Investing Cash Flow | -0.01 | -0.24 | -0.8 | - | 23.2 | -23.29 | Upgrade
|
Long-Term Debt Issued | - | - | - | 0.95 | - | - | Upgrade
|
Short-Term Debt Repaid | - | -1.33 | -0.62 | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | - | - | -0.14 | -0.08 | - | Upgrade
|
Total Debt Repaid | -1.15 | -1.33 | -0.62 | -0.14 | -0.08 | - | Upgrade
|
Net Debt Issued (Repaid) | 0.85 | -1.33 | -0.62 | 0.81 | -0.08 | - | Upgrade
|
Issuance of Common Stock | 3.5 | 0.2 | 68.28 | 30.01 | 28.49 | 42.64 | Upgrade
|
Repurchase of Common Stock | -0.02 | -0.05 | -0.24 | -0.29 | -0.13 | -0.18 | Upgrade
|
Other Financing Activities | -0.79 | 0.01 | 0.79 | -2.13 | -1.08 | -3.58 | Upgrade
|
Financing Cash Flow | 3.54 | -1.16 | 68.21 | 28.4 | 27.2 | 38.88 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.08 | -0.11 | -0.02 | -0.05 | -0.05 | -0.01 | Upgrade
|
Net Cash Flow | -21.55 | -33.65 | 25.6 | -4.79 | 21.34 | -7.64 | Upgrade
|
Free Cash Flow | -25.01 | -32.38 | -42.1 | -33.15 | -29.01 | -23.29 | Upgrade
|
Free Cash Flow Per Share | -12.57 | -18.13 | -28.15 | -44.10 | -90.50 | -127.69 | Upgrade
|
Cash Interest Paid | 0.03 | 0.02 | 0.01 | 0 | 0 | - | Upgrade
|
Cash Income Tax Paid | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Levered Free Cash Flow | -16.43 | -21.63 | -26.27 | -17.5 | -17.11 | -10.32 | Upgrade
|
Unlevered Free Cash Flow | -16.41 | -21.62 | -26.26 | -17.49 | -17.1 | -10.32 | Upgrade
|
Change in Net Working Capital | -1.79 | 1 | 3.09 | -4.21 | 2.67 | -1.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.